The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Nanoparticle Vaccines Against Infectious Diseases
Open accessAbstract
Due to emergence of new variants of pathogenic micro-organisms the treatment and immunization of infectious diseases have become a great challenge in the past few years. In the context of vaccine development remarkable efforts have been made to develop new vaccines and also to improve the efficacy of existing vaccines against specific diseases. To date, some vaccines are developed from protein subunits or killed pathogens, whilst several vaccines are based on live-attenuated organisms, which carry the risk of regaining their pathogenicity under certain immunocompromised conditions. To avoid this, the development of risk-free effective vaccines in conjunction with adequate delivery systems are considered as an imperative need to obtain desired humoral and cell-mediated immunity against infectious diseases. In the last several years, the use of nanoparticle-based vaccines has received a great attention to improve vaccine efficacy, immunization strategies, and targeted delivery to achieve desired immune responses at the cellular level. To improve vaccine efficacy, these nanocarriers should protect the antigens from premature proteolytic degradation, facilitate antigen uptake and processing by antigen presenting cells, control release, and should be safe for human use. Nanocarriers composed of lipids, proteins, metals or polymers have already been used to attain some of these attributes. In this context, several physico-chemical properties of nanoparticles play an important role in the determination of vaccine efficacy. This review article focuses on the applications of nanocarrier-based vaccine formulations and the strategies used for the functionalization of nanoparticles to accomplish efficient delivery of vaccines in order to induce desired host immunity against infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Feng, G., Jiang, Q., Xia, M., Lu, Y., Qiu, W., Zhao, D., Lu, L., Peng, G., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061135 · Cited by 108
RetractedA study of the nucleation and growth processes in the synthesis of colloidal gold
Turkevich, J., Stevenson, P. C., & Hillier, J. (1951) · Discussions of the Faraday Society · doi:10.1039/df9511100055 · Cited by 7,792
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 2×
“Conjugation of CD47 molecules on the surface of NPs modulated the down-stream signaling cascades and also reduced NP internalization by phagocytic cells (131).”
BackgroundPathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Protein-nanoparticle interactions
Lynch, I., & Dawson, K. A. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70014-8 · Cited by 1,727
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,324
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
Shvedova, A. A., Kisin, E. R., Mercer, R., Murray, A. R., Johnson, V. J., Potapovich, A. I., Tyurina, Y. Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., et al. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00084.2005 · Cited by 1,312
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type
Kostarelos, K., Lacerda, L., Pastorin, G., Wu, W., Wieckowski, S., Luangsivilay, J., Godefroy, S., Pantarotto, D., Briand, J.-P., Muller, S., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2006.209 · Cited by 1,111
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022 · cited 2×
“This was demonstrated by the fact that although nano rods and nano sheets were internalized via clathrin mediated endocytosis, nano rods were particularly delivered to the nucleus while nanosheet were retained in the cytoplasm (146, 147, 155).”
BackgroundThe contribution of vaccination to global health: past, present and future
Greenwood, B. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0433 · Cited by 979
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933 · cited 1×
“Silica based NPs contain abundant silanol groups that can be utilized to introduce specific functional groups on their surface to gain access for vaccine molecules into target cells (84) (85) (86) .”
BackgroundMinireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914 · cited 2×
“Interestingly, pulmonary instillation of cationic and anionic NPs showed similar endocytosis rate in macrophages and draining lymph nodes, however cationic formulations showed more expression of Ccl2 and Cxc10 chemokines that caused more recruitment and maturation of CD11b DCs in comparison to anionic NPs in the lung…”
BackgroundResultA Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules
Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884
Silica Nanoparticle Size Influences the Structure and Enzymatic Activity of Adsorbed Lysozyme
Vertegel, A. A., Siegel, R. W., & Dordick, J. S. (2004) · Langmuir · doi:10.1021/la0497200 · Cited by 878
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
Applications of nanotechnology for immunology
Smith, D. M., Simon, J. K., & Baker Jr, J. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3488 · Cited by 767
The physiology of the lymphatic system
Swartz, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00150-8 · Cited by 737
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Niikura, K., Matsunaga, T., Suzuki, T., Kobayashi, S., Yamaguchi, H., Orba, Y., Kawaguchi, A., Hasegawa, H., Kajino, K., Ninomiya, T., et al. (2013) · ACS Nano · doi:10.1021/nn3057005 · Cited by 638
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 591
Virus-like particles: Passport to immune recognition
Grgacic, E. V. L., & Anderson, D. A. (2006) · Methods · doi:10.1016/j.ymeth.2006.07.018 · Cited by 582
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Lynch, I., Salvati, A., & Dawson, K. A. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.248 · Cited by 551
Oyewumi, M. O., Kumar, A., & Cui, Z. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.89 · Cited by 547
Construction and Characterization of Virus-Like Particles: A Review
Zeltins, A. (2013) · Molecular Biotechnology · doi:10.1007/s12033-012-9598-4 · Cited by 478
Induction of secretory immunity and memory at mucosal surfaces
Brandtzaeg, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.001 · Cited by 472
Migration of Dendritic Cell Subsets and their Precursors
Randolph, G. J., Ochando, J., & Partida-Sánchez, S. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090254 · Cited by 466
DNA Vaccines: Progress and Challenges
Donnelly, J. J., Wahren, B., & Liu, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.633 · Cited by 448
Lynn, G. M., Laga, R., Darrah, P. A., Ishizuka, A. S., Balaci, A. J., Dulcey, A. E., Pechar, M., Pola, R., Gerner, M. Y., Yamamoto, A., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3371 · Cited by 440
Infection-mimicking materials to program dendritic cells in situ
Ali, O. A., Huebsch, N., Cao, L., Dranoff, G., & Mooney, D. J. (2009) · Nature Materials · doi:10.1038/nmat2357 · Cited by 434
Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421
Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., & Hanlon, D. J. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02268.x · Cited by 420
Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
The Role of Surface Functionality in Determining Nanoparticle Cytotoxicity
Kim, S. T., Saha, K., Kim, C., & Rotello, V. M. (2013) · Accounts of Chemical Research · doi:10.1021/ar3000647 · Cited by 403
Harding, C. V., & Song, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4925 · Cited by 383
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Recombinant vaccines and the development of new vaccine strategies
Nascimento, I. P., & Leite, L. C. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500142 · Cited by 367
After 2015: infectious diseases in a new era of health and development
Dye, C. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0426 · Cited by 361
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment
Xu, L., Liu, Y., Chen, Z., Li, W., Liu, Y., Wang, L., Liu, Y., Wu, X., Ji, Y., Zhao, Y., et al. (2012) · Nano Letters · doi:10.1021/nl300027p · Cited by 320
Yu, M., Jambhrunkar, S., Thorn, P., Chen, J., Gu, W., & Yu, C. (2013) · Nanoscale · doi:10.1039/c2nr32145a · Cited by 316
Quan, F.-S., Huang, C., Compans, R. W., & Kang, S.-M. (2007) · Journal of Virology · doi:10.1128/jvi.02052-06 · Cited by 313
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Demento, S. L., Cui, W., Criscione, J. M., Stern, E., Tulipan, J., Kaech, S. M., & Fahmy, T. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.041 · Cited by 304
Mottram, P. L., Leong, D., Crimeen-Irwin, B., Gloster, S., Xiang, S. D., Meanger, J., Ghildyal, R., Vardaxis, N., & Plebanski, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060096p · Cited by 296
Reis e Sousa, C., & Germain, R. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.841 · Cited by 296
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.106 · Cited by 288
Chu, D., Gao, J., & Wang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b05583 · Cited by 283
Maurer, P., Jennings, G. T., Willers, J., Rohner, F., Lindman, Y., Roubicek, K., Renner, W. A., Müller, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526285 · Cited by 279 · cited 11×
“It is also possible to chemically couple non-protein antigens and small organic molecules onto the viral surface to produce bioconjugates with VLPs (118, 119).”
BackgroundInfluentialThe Control of Adaptive Immune Responses by the Innate Immune System
Schenten, D., & Medzhitov, R. (2011) · Advances in Immunology · doi:10.1016/b978-0-12-387664-5.00003-0 · Cited by 279
Bioconjugated Nanoparticles for DNA Protection from Cleavage
He, X.-X., Wang, K., Tan, W., Liu, B., Lin, X., He, C., Li, D., Huang, S., & Li, J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034450d · Cited by 266
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
Vyas, S. P., Kannan, M. E., Jain, S., Mishra, V, & Singh, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Andersen, P., & Agger, E. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.17 · Cited by 259
de Titta, A., Ballester, M., Julier, Z., Nembrini, C., Jeanbart, L., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313152110 · Cited by 254
Sonaje, K., Chuang, E.-Y., Lin, K.-J., Yen, T.-C., Su, F.-Y., Tseng, M. T., & Sung, H.-W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200572t · Cited by 253
Chackerian, B., Lowy, D. R., & Schiller, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11849 · Cited by 251
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells
Harding, C. V., Collins, D. S., Slot, J. W., Geuze, H. J., & Unanue, E. R. (1991) · Cell · doi:10.1016/0092-8674(91)90647-h · Cited by 250
Intracellular mechanisms of antigen cross presentation in dendritic cells
Amigorena, S., & Savina, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.022 · Cited by 247
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
Sunshine, J. C., Perica, K., Schneck, J. P., & Green, J. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.050 · Cited by 244
Thomas, C., Rawat, A., Hope-Weeks, L., & Ahsan, F. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100255c · Cited by 241
Bright, R. A., Carter, D. M., Crevar, C. J., Toapanta, F. R., Steckbeck, J. D., Cole, K. S., Kumar, N. M., Pushko, P., Smith, G., Tumpey, T. M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001501 · Cited by 240
Vallhov, H., Qin, J., Johansson, S. M., Ahlborg, N., Muhammed, M. A., Scheynius, A., & Gabrielsson, S. (2006) · Nano Letters · doi:10.1021/nl060860z · Cited by 238
Biodegradable Particles as Vaccine Delivery Systems: Size Matters
Joshi, V. B., Geary, S. M., & Salem, A. K. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9418-6 · Cited by 233
Hirosue, S., Kourtis, I. C., van der Vlies, A. J., Hubbell, J. A., & Swartz, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.077 · Cited by 233
Allen, T. M., Hansen, C. B., & Guo, L. S. S. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90115-g · Cited by 228
Recombinant Norwalk virus–like particles given orally to volunteers: Phase I study
Ball, J. M., Graham, D. Y., Opekun, A. R., Gilger, M. A., Guerrero, R. A., & Estes, M. K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70548-2 · Cited by 227
Storm, G., & Crommelin, D. J. A. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00007-8 · Cited by 224
Lymphatic targeting with nanoparticulate system
Nishioka, Y., & Yoshino, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00121-6 · Cited by 223
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Kamaly, N., Fredman, G., Subramanian, M., Gadde, S., Pesic, A., Cheung, L., Fayad, Z. A., Langer, R., Tabas, I., & Cameron Farokhzad, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303377110 · Cited by 214
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
Tissot, A. C., Renhofa, R., Schmitz, N., Cielens, I., Meijerink, E., Ose, V., Jennings, G. T., Saudan, P., Pumpens, P., & Bachmann, M. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009809 · Cited by 206
Villa, C. H., Dao, T., Ahearn, I., Fehrenbacher, N., Casey, E., Rey, D. A., Korontsvit, T., Zakhaleva, V., Batt, C. A., Philips, M. R., et al. (2011) · ACS Nano · doi:10.1021/nn200182x · Cited by 205
Goldinger, S. M., Dummer, R., Baumgaertner, P., Mihic‐Probst, D., Schwarz, K., Hammann‐Haenni, A., Willers, J., Geldhof, C., Prior, J. O., Kündig, T. M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142361 · Cited by 201
Chitosan-based nanoparticles for improving immunization against hepatitis B infection
Prego, C., Paolicelli, P., Díaz, B., Vicente, S., Sánchez, A., González-Fernández, Á., & Alonso, M. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.011 · Cited by 189
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
Nembrini, C., Stano, A., Dane, K. Y., Ballester, M., van der Vlies, A. J., Marsland, B. J., Swartz, M. A., & Hubbell, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104264108 · Cited by 187
Cytokines in the systemic inflammatory response syndrome: a review.
Jaffer, U., Wade, R. G., & Gourlay, T. (2010) · Europe PMC (PubMed Central) · Cited by 187
Thiele, L., Merkle, H. P., & Walter, E. (2003) · Pharmaceutical Research · doi:10.1023/a:1022271020390 · Cited by 183
Rotavirus virus-like particles administered mucosally induce protective immunity
O'Neal, C. M., Crawford, S. E., Estes, M. K., & Conner, M. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8707-8717.1997 · Cited by 183
Pimentel, T. A. P. F., Yan, Z., Jeffers, S. A., Holmes, K. V., Hodges, R. S., & Burkhard, P. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00746.x · Cited by 182
Patel, K. G., & Swartz, J. R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100367u · Cited by 182
Diwan, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00275-4 · Cited by 177
Chen, Y.-S., Hung, Y.-C., Lin, W.-H., & Huang, G. S. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/19/195101 · Cited by 176
Kaba, S. A., Brando, C., Guo, Q., Mittelholzer, C., Raman, S., Tropel, D., Aebi, U., Burkhard, P., & Lanar, D. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901957 · Cited by 175
Akagi, T., Wang, X., Uto, T., Baba, M., & Akashi, M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.023 · Cited by 173
Honda-Okubo, Y., Saade, F., & Petrovsky, N. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.021 · Cited by 169
Laroui, H., Viennois, E., Xiao, B., Canup, B. S. B., Geem, D., Denning, T. L., & Merlin, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.046 · Cited by 163
Pawar, D., Mangal, S., Goswami, R., & Jaganathan, K. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.06.017 · Cited by 161
Ball, J. M., Hardy, M. E., Atmar, R. L., Conner, M. E., & Estes, M. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1345-1353.1998 · Cited by 160
Li, P., Luo, Z., Liu, P., Gao, N., Zhang, Y., Pan, H., Liu, L., Wang, C., Cai, L., & Ma, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.025 · Cited by 158
Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., de Sousa, A., Borchard, G., & Junginger, H. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.019 · Cited by 158
Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen
Slütter, B., Soema, P. C., Ding, Z., Verheul, R. J., Hennink, W. E., & Jiskoot, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.007 · Cited by 156
Chemical Modification of Viruses and Virus-Like Particles
Strable, E., & Finn, M. G. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69379-6_1 · Cited by 151
Schöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Dowling, D. J., Scott, E. A., Scheid, A., Bergelson, I., Joshi, S., Pietrasanta, C., Brightman, S. E., Sánchez‐Schmitz, G., van Haren, S. D., Ninković, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.985 · Cited by 147
Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H. H., & Liesenfeld, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00660-3 · Cited by 145
Saadé, F., Honda‐Okubo, Y., Trec, S., & Petrovsky, N. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.077 · Cited by 141
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
Khatri, K., Goyal, A. K., Gupta, P. N., Mishra, N., & Vyas, S. P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.027 · Cited by 140
Raghuvanshi, R. S., Katare, Y. K., Lalwani, K., Ali, M. M., Singh, O., & Panda, A. K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00342-3 · Cited by 140
Altenburg, A. F., Kreijtz, J. H. C. M., de Vries, R. D., Song, F., Fux, R., Rimmelzwaan, G. F., Sutter, G., & Volz, A. (2014) · Viruses · doi:10.3390/v6072735 · Cited by 135
Bielinska, A. U., Janczak, K. W., Landers, J. J., Makidon, P. E., Sower, L. E., Peterson, J. W., & Baker, J. R. (2007) · Infection and Immunity · doi:10.1128/iai.00070-07 · Cited by 135
Mahmood, K., Bright, R. A., Mytle, N., Carter, D. M., Crevar, C. J., Achenbach, J. E., Heaton, P. M., Tumpey, T. M., & Ross, T. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.084 · Cited by 133
Crooks, E. T., Moore, P. L., Franti, M., Cayanan, C. S., Zhu, P., Jiang, P., de Vries, R. P., Wiley, C. L., Zharkikh, I. L., Schülke, N., et al. (2007) · Virology · doi:10.1016/j.virol.2007.04.033 · Cited by 132
Ballester, M., Nembrini, C., Dhar, N., de Titta, A., de Piano, C., Pasquier, M., Simeoni, E., van der Vlies, A. J., McKinney, J. D., Hubbell, J. A., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.039 · Cited by 130
Zhou, X., Zhang, X., Yu, X., Zha, X., Fu, Q., Liu, B., Wang, X., Chen, Y., Chen, Y., Shan, Y., et al. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.007 · Cited by 130
Béduneau, A., Ma, Z., Grotepas, C. B., Kabanov, A. V., Rabinow, B. E., Gong, N., Mosley, R. L., Dou, H., Boska, M. D., & Gendelman, H. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004343 · Cited by 128
Kim, Y., Pan, J. Y.-J., Korbel, G. A., Peperzak, V., Boes, M. L., & Ploegh, H. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511315103 · Cited by 125
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
Bershteyn, A., Hanson, M. C., Crespo, M. P., Moon, J. J., Li, A. V., Suh, H., & Irvine, D. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.029 · Cited by 118
Liposome-Based Delivery System for Vaccine Candidates: Constructing An Effective Formulation
Giddam, A. K., Zaman, M., Skwarczyński, M., & Tóth, I. (2012) · Nanomedicine · doi:10.2217/nnm.12.157 · Cited by 117
Cross‐presentation: dendritic cells and macrophages bite off more than they can chew!
Brode, S., & MacAry, P. A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01920.x · Cited by 113
van der Vlies, A. J., O’Neil, C. P., Hasegawa, U., Hammond, N. A., & Hubbell, J. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9004443 · Cited by 111
Romalde, J. L., Álvarez, A. L., Ravelo, C., Toranzo, A. E., & Blanco-Méndez, J. (2004) · Aquaculture · doi:10.1016/j.aquaculture.2004.02.028 · Cited by 110
Dane, K. Y., Nembrini, C., Tomei, A. A., Eby, J. K., O’Neil, C. P., Velluto, D., Swartz, M. A., Inverardi, L., & Hubbell, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.009 · Cited by 109
Manish, M., Rahi, A., Kaur, M., Bhatnagar, R., & Singh, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061885 · Cited by 108
Liposomal adjuvants for human vaccines
Alving, C. R., Beck, Z., Matyas, G. R., & Rao, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1151871 · Cited by 108
Joseph, A., Itskovitz-Cooper, N., Samira, S., Flasterstein, O., Eliyahu, H., Simberg, D., Goldwaser, I., Barenholz, Y., & Kedar, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.12.017 · Cited by 105
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Sawaengsak, C., Mori, Y., Yamanishi, K., Mitrevej, A., & Sinchaipanid, N. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0058-7 · Cited by 105
Wang, T., Zou, M., Jiang, H., Ji, Z., Gao, P. H., & Cheng, G. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.012 · Cited by 103
Pusic, K. M., Aguilar, Z. P., McLoughlin, J., Kobuch, S., Xu, H. T., Tsang, M., Wang, A., & Hui, G. S. N. (2012) · The FASEB Journal · doi:10.1096/fj.12-218362 · Cited by 103
Kamath, A. T., Rochat, A., Christensen, D., Agger, E. M., Andersen, P. L., Lambert, P., & Siegrist, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005771 · Cited by 101
A Practical Approach to the use of Nanoparticles for Vaccine Delivery
Wendorf, J. R., Singh, M., Chesko, J., Kazzaz, J., Soewanan, E., Ugozzoli, M., & O’Hagan, D. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20728 · Cited by 100
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages
Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100
Tao, W., & Gill, H. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.063 · Cited by 99
Richards, R. L., Rao, M., Wassef, N. M., Glenn, G. M., Rothwell, S. W., & Alving, C. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2859-2865.1998 · Cited by 99
Lu, F., Mencía, A., Bi, L., Taylor, A., Yao, Y., & HogenEsch, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.002 · Cited by 98
Braden, C. R., Dowell, S. F., Jernigan, D. B., & Hughes, J. M. (2013) · Emerging infectious diseases · doi:10.3201/eid1906.130192 · Cited by 93
Silva, C. L., Bonato, V. L. D., Coelho‐Castelo, A. A. M., de Souza, A. O., Santos, S. A., Lima, K. M., Faccioli, L. H., & Júnior, J. M. R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302418 · Cited by 92
Alving, C. R., Richards, R. L., Moss, J., Alving, L. I., Clements, J. D., Shiba, T., Kotani, S., Wirtz, R. A., & Hockmeyer, W. T. (1986) · Vaccine · doi:10.1016/0264-410x(86)90005-8 · Cited by 91
de Lima, V. M. F., Bonato, V. L. D., de Lima, K. M. C., SANTOS, S. A. D., Santos, R. R., Gonçalves, E. D. C., Faccioli, L. H., Brandão, I. T., Júnior, J. M. R., & Silva, C. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5305-5312.2001 · Cited by 88
Wang, B., Liu, W., Kang, S., Alam, M. S., Huang, C., Ye, L., Sun, Y., Li, Y., Kothe, D. L., Pushko, P., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00542-07 · Cited by 85
Stano, A., Nembrini, C., Swartz, M. A., Hubbell, J. A., & Simeoni, E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.050 · Cited by 84
Abraham, E. H. (1992) · Vaccine · doi:10.1016/0264-410x(92)90395-z · Cited by 83
Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
Gao, Y., Wijewardhana, C. N., & Mann, J. F. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00345 · Cited by 83
Jain, S., Yap, W. T., & Irvine, D. J. (2005) · Biomacromolecules · doi:10.1021/bm0503221 · Cited by 81
Parez, N., Fourgeux, C., Si‐Mohamed, A., Dubuquoy, C., Pillot, M., Dehée, A., Charpilienne, A., Poncet, D., Schwartz-Cornil, I., & Garbarg‐Chenon, A. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1752-1761.2006 · Cited by 80
Biabanikhankahdani, R., Alitheen, N. B., Ho, K. L., & Tan, W. S. (2016) · Scientific Reports · doi:10.1038/srep37891 · Cited by 79
Li, A., Qin, L., Zhu, D., Zhu, R., Sun, J., & Wang, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.095 · Cited by 73
Xue, T., Stavropoulos, E., Yang, M., Ragno, S., Vordermeier, M., Chambers, M., Hewinson, G., Lowrie, D. B., Colston, M. J., & Tascon, R. E. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6324-6329.2004 · Cited by 73
de la Rosa, G. P., Monroy, A., Mora‐García, M. D. L., Reynaga‐Peña, C. G., Hernández‐Montes, J., Weiss‐Steider, B., & Gómez-Lim, M. Á. (2009) · Virology Journal · doi:10.1186/1743-422x-6-2 · Cited by 72
Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity
Gregory, A. E., Williamson, E. D., Prior, J. L., Butcher, W. A., Thompson, I. J., Shaw, A. M., & Titball, R. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.021 · Cited by 68
Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid
Reid, G. (1992) · Vaccine · doi:10.1016/0264-410x(92)90439-q · Cited by 66
Scallan, C. D., Tingley, D. W., Lindbloom, J. D., Toomey, J. S., & Tucker, S. N. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00552-12 · Cited by 66
Makidon, P. E., Knowlton, J., Groom, J. V., et al. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0137-2 · Cited by 65
Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection
Perisé-Barrios, A. J., Jiménez, J. L., Domínguez‐Soto, Á., de la Mata, F. J., Corbí, A. L., Gómez, R., & Muñoz‐Fernández, M. Á. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.048 · Cited by 64
Influenza virosomes as an efficient system for adjuvanted vaccine delivery
Glück, R., Moser, C., & Metcalfe, I. C. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1139 · Cited by 63
Matassov, D., Cupo, A., & Galarza, J. M. (2007) · Viral Immunology · doi:10.1089/vim.2007.0027 · Cited by 62
Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles
Guo, L., Lu, X., Kang, S., Chen, C., Compans, R. W., & Yao, Q. C. (2003) · Virology · doi:10.1016/s0042-6822(03)00372-6 · Cited by 60
Tanaka, Y., Taneichi, M., Kasai, M., Kakiuchi, T., & Uchida, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015225 · Cited by 56
Meerak, J., Wanichwecharungruang, S. P., & Palaga, T. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.075 · Cited by 54
High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines
Stieneker, F., Kreuter, J., & Löwer, J. (1991) · AIDS · doi:10.1097/00002030-199104000-00012 · Cited by 53
Beverley, P. C. L. (2002) · British Medical Bulletin · doi:10.1093/bmb/62.1.15 · Cited by 53
Margaroni, M., Agallou, M., Athanasiou, E., Kammona, O., Kiparissides, C. A., Gaitanaki, C., & Karagouni, E. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s141069 · Cited by 53
Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole
Lim, J.-S., Lee, K., Choi, J.-N., Hwang, Y., Yun, M.-Y., Kim, H.-J., Won, Y. S., Kim, S., Kwon, H., & Huh, S. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/8/085101 · Cited by 52
Wang, X., Uto, T., Akagi, T., Akashi, M., & Baba, M. (2007) · Journal of Virology · doi:10.1128/jvi.00489-07 · Cited by 52
Li, X., Deng, X., & Huang, Z. (2001) · Pharmaceutical Research · doi:10.1023/a:1011043230573 · Cited by 49
Al-Deen, F. M. N., Selomulya, C., Kong, Y., Xiang, S. D., Ma, C., Coppel, R. L., & Plebanski, M. (2013) · Gene Therapy · doi:10.1038/gt.2013.77 · Cited by 48
Nanobiotechnological Approaches to Delivery of DNA Vaccine Against Fungal Infection
Ribeiro, A. M., Souza, A. C. O., Amaral, A. C., Vasconcelos, N. ‐., Jerônimo, M. S., Carneiro, F. P., Faccioli, L. H., Felipe, M. S. S., Silva, C. L., & Bocca, A. L. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1491 · Cited by 47
Enhanced Anti-HIV Efficacy of Indinavir After Inclusion in CD4-Targeted Lipid Nanoparticles
Endsley, A. N., & Ho, R. J. Y. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182653c1f · Cited by 47
Hernández‐Gil, J., Cobaleda‐Siles, M., Zabaleta, A., Salassa, L., Calvo, J., & Rivas, J. C. M. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500080 · Cited by 46
Fernandez, É. M., Chang, J., Fontaine, J., Bialecki, E., Rodriguez, F., Werkmeister, E., Krieger, V., Ehret, C., Heurtault, B., Fournel, S., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.068 · Cited by 46
Sehgal, K., Ragheb, R. R. T., Fahmy, T. M., Dhodapkar, M. V., & Dhodapkar, K. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400489 · Cited by 45
Gene delivery using cationic liposomes
McNeil, S. E., & Perrie, Y. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.10.1371 · Cited by 44
Das, I., Padhi, A., Mukherjee, S., Dash, D. P., Kar, S. K., & Sonawane, A. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa60fd · Cited by 41
Self-citationHa, S., Park, S., Kim, H.-J., Kim, S., Kang, H.-J., Lee, E.-G., Kwon, S.-G., Kim, B.-M., Lee, S.-H., Kim, W. B., et al. (2006) · Infection and Immunity · doi:10.1128/iai.01781-05 · Cited by 40
Influenza vaccines: from whole virus preparations to recombinant protein technology
Huber, V. C. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2014.852476 · Cited by 38
Homhuan, A., Prakongpan, S., Poomvises, P., Maas, R. A., Crommelin, D. J. A., Kersten, G. F. A., & Jiskoot, W. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.05.005 · Cited by 38
Development of Tat-Conjugated Dendrimer for Transdermal DNA Vaccine Delivery
Bahadoran, A., Moeini, H., Bejo, M. H., Hussein, M. Z., & Omar, A. R. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3g31q · Cited by 38
Mundayoor, S., Kumar, & Dhanasooraj (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40238 · Cited by 36
Speth, M. T., Repnik, U., Müller, E., Spanier, J., Kalinke, U., Corthay, A., & Griffiths, G. W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00795 · Cited by 34
Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force
Tyagi, R. K., Garg, N. K., & Sahu, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.037 · Cited by 33
Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis
Wejse, C. M., Patsche, C. B., Kühle, A., Bamba, F. J. V., Mendes, M. S., Lemvik, G., Gomes, V., & Rudolf, F. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.12.015 · Cited by 33
Ichihashi, T., Satoh, T., Sugimoto, C., & Kajino, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060068 · Cited by 32
Kang, S., Lee, Y., Ko, E., Hwang, H. S., Lee, J. S., Kim, K., & Kwon, Y. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s83493 · Cited by 30
Swine and Influenza: A Challenge to One Health Research
Kahn, R. E., Ma, W., & Richt, J. A. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_392 · Cited by 28
Poecheim, J., Barnier-Quer, C., Collin, N., & Borchard, G. (2016) · Vaccines · doi:10.3390/vaccines4030032 · Cited by 25
SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier
Kawano, M., Matsui, M., & Handa, H. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.149 · Cited by 21
Plasmodium vinckei:Optimization of Desferrioxamine B Delivery in the Treatment of Murine Malaria
Postma, N. S., Hermsen, C. C., Zuidema, J., & Eling, W. M. C. (1998) · Experimental Parasitology · doi:10.1006/expr.1998.4282 · Cited by 20
Toki, S., Omary, R. A., Wilson, K., Gore, J. C., Peebles, R. S., & Pham, W. N. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.05.010 · Cited by 19
Campbell, D. F., Saenz, R., Bharati, I. S., Seible, D. M., Zhang, L., Esener, S. C., Messmer, B. T., Larsson, M., & Messmer, D. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0552-9 · Cited by 19
Killion, J. J., Fishbeck, R., Bar‐Eli, M., & Chernajovsky, Y. (1994) · Cytokine · doi:10.1016/1043-4666(94)90069-8 · Cited by 17
Li, M., Wang, B., Wu, Z., Shi, X., Zhang, J., & Han, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3486-z · Cited by 15
Amini, Y., Moradi, B., Tafaghodi, M., et al. (2016) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-016-0326-y · Cited by 12
Cited by
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Chauhan, G., Madou, M. J., Kalra, S., Chopra, V., Ghosh, D., & Martinez-Chapa, S. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04006 · Cited by 385
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Chung, Y. H., Beiss, V., Fiering, S. N., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 346
Emerging Concepts and Technologies in Vaccine Development
Brisse, M., Vrba, S. M., Kirk, N., Liang, Y., & Ly, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583077 · Cited by 323
Gaur, M., Misra, C., Yadav, A. B., Swaroop, S., Maolmhuaidh, F. Ó., Bechelany, M., & Barhoum, A. (2021) · Materials · doi:10.3390/ma14205978 · Cited by 317
Metadata
- Authors
- Pati, R., Shevtsov, M., & Sonawane, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-04
- Volume
- 9
- Pages
- 2224-2224
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2895497426
- Cited by
- 514
- References
- 197
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.